Thrombocytopenic, thromboembolic and haemorrhagic events following second dose with BNT162b2 and ChAdOx1: self-controlled case series analysis of the English national sentinel cohort

BACKGROUND: Thrombosis associated with thrombocytopenia was a matter of concern post first and second doses of BNT162b2 and ChAdOx1 COVID-19 vaccines. Therefore, it is important to investigate the risk of thrombocytopenic, thromboembolic and haemorrhagic events following a second dose of BNT162b2 an...

Descripción completa

Detalles Bibliográficos
Autores principales: Joy, Mark, Agrawal, Utkarsh, Fan, Xuejuan, Robertson, Chris, Anand, Sneha N., Ordonez-Mena, Jose, Byford, Rachel, Goudie, Rosalind, Jamie, Gavin, Kar, Debasish, Williams, John, Marsden, Gemma L., Tzortziou-Brown, Victoria, Sheikh, Sir Aziz, Hobbs, F.D. Richard, de Lusignan, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477035/
https://www.ncbi.nlm.nih.gov/pubmed/37671127
http://dx.doi.org/10.1016/j.lanepe.2023.100681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477035/
https://www.ncbi.nlm.nih.gov/pubmed/37671127
http://dx.doi.org/10.1016/j.lanepe.2023.100681

Ejemplares similares